The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro.
about
The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The PNPLA3 I148M variant is as ...... with basal insulin peglispro.
@en
The PNPLA3 I148M variant is as ...... with basal insulin peglispro.
@nl
type
label
The PNPLA3 I148M variant is as ...... with basal insulin peglispro.
@en
The PNPLA3 I148M variant is as ...... with basal insulin peglispro.
@nl
prefLabel
The PNPLA3 I148M variant is as ...... with basal insulin peglispro.
@en
The PNPLA3 I148M variant is as ...... with basal insulin peglispro.
@nl
P2093
P2860
P356
P1476
The PNPLA3 I148M variant is as ...... with basal insulin peglispro.
@en
P2093
B Hoogwerf
P Bhatnagar
P2860
P2888
P356
10.1038/TPJ.2017.45
P577
2017-11-21T00:00:00Z